0001104659-24-048338.txt : 20240417
0001104659-24-048338.hdr.sgml : 20240417
20240417163031
ACCESSION NUMBER: 0001104659-24-048338
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240405
FILED AS OF DATE: 20240417
DATE AS OF CHANGE: 20240417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CONTE LISA A
CENTRAL INDEX KEY: 0001008377
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36714
FILM NUMBER: 24851463
MAIL ADDRESS:
STREET 1: 213 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jaguar Health, Inc.
CENTRAL INDEX KEY: 0001585608
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 PINE STREET SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-371-8300
MAIL ADDRESS:
STREET 1: 200 PINE STREET SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
FORMER COMPANY:
FORMER CONFORMED NAME: Jaguar Animal Health, Inc.
DATE OF NAME CHANGE: 20130830
4
1
tm2411853-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-04-05
0
0001585608
Jaguar Health, Inc.
JAGX
0001008377
CONTE LISA A
C/O JAGUAR HEALTH, INC.
200 PINE STREET, SUITE 400
SAN FRANCISCO
CA
94104
1
1
0
0
CEO and President
0
Common Stock
2024-04-05
4
M
0
600
A
4600
D
Restricted stock units
2024-04-05
4
A
0
600
0
D
Common Stock
600
0
D
Restricted stock units convert into common stock on a one-for-one basis.
On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock. On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "September 2021 Reverse Stock Split"). Upon effectiveness of the September 2021 Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock.
The restricted stock units were previously reported as covering 405,000 shares, but were adjusted to reflect the September 2021 Reverse Stock Split and January 2023 Reverse Stock Split. Such restricted stock units were granted on April 5, 2021 and vest in three equal annual installments beginning on April 5, 2022, the first anniversary of the grant date.
/s/ Lisa A. Conte
2024-04-17